Literature DB >> 25965906

A clinicopathologic study of morphea in Korean patients.

Jeong Ho Hong1, Jeong Eun Kim1, Joo Yeon Ko1, Young Suck Ro1.   

Abstract

BACKGROUND: The exact pathogenesis of morphea is poorly understood, and only a few clinical or histopathological studies have been conducted in Asian patients.
OBJECTIVE: The aim of this study was to identify the clinical and histopathological characteristics of morphea in Korean patients.
METHODS: We retrospectively reviewed the medical records of 101 patients whose clinicopathologic findings were compatible with morphea and analyzed demographic characteristics, number of lesions, disease subtype and histopathological findings.
RESULTS: Overall, circumscribed morphea (52.5%) was the most common clinical type, followed by linear (28.7%), mixed (13.9%) and generalized (5.0%) type. Disease duration was positively correlated with increased thickness of the skin in 54 patients (p < 0.001). Inflammatory cell infiltration was absent in 54, mild in 30 and moderate in 14 patients. There was no significant difference in the mean ratio of lesional to normal skin thickness (L/N ratio) among four types of morphea. Disease duration was not correlated with the density of inflammatory cell infiltration (p = 0.68). There were statistically significant differences in the duration of disease according to plasma cell counts (p < 0.05).
CONCLUSIONS: A positive correlation was found between skin thickness and disease duration, but mean L/N ratio was not significantly different among various types of morphea.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Korea; morphea; scleroderma

Year:  2015        PMID: 25965906     DOI: 10.1111/cup.12528

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  1 in total

1.  Early morphea simulating patch-stage mycosis fungoides in two cases.

Authors:  Hamid R Ghasemi Basir; Pedram Alirezaei; Aliasghar Rezanejad; Sajjad Daneshyar
Journal:  Dermatol Reports       Date:  2018-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.